Related Experiment Videos
Staging of localized prostate cancer: a clinical-pathologic correlation
E Mukamel1, J B de Kernion, J Hannah
1Departement of Surgery, UCLA School of Medicine 90024.
Journal D'Urologie
|January 1, 1988
Summary
Accurate clinical staging is crucial for prostate cancer patients. Digital rectal examination, bone scans, and imaging like MRI/CT often understage tumors, impacting treatment decisions.
Area of Science:
- Urology
- Oncology
- Radiology
Background:
- Accurate staging of prostate cancer is essential for treatment planning.
- Clinical staging methods often have limitations in precisely determining tumor extent.
Purpose of the Study:
- To evaluate the accuracy of clinical staging methods for prostate cancer.
- To compare the effectiveness of digital rectal examination, bone scans, MRI, and CT in staging.
Main Methods:
- Sixty patients underwent clinical staging (digital rectal examination, acid phosphatase, bone scan) before surgery.
- Twenty-one patients also had pelvic MRI and CT scans.
- Pathologic staging was performed on surgical specimens.
Main Results:
- Understaging occurred in 27% of B1 and 67% of B2 patients.
- Capsular invasion and seminal vesicle extension were frequent in B1 and B2 stages.
- Lymph node metastases were observed in 29% of B2 patients.
- Neither CT nor MRI improved staging accuracy over digital rectal examination.
Conclusions:
- Clinical staging methods, including advanced imaging, frequently understage prostate cancer.
- Tumor size, grade, and prior treatments influence staging accuracy.
- Pathologic staging remains critical for definitive prostate cancer assessment.